The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Larotrectinib
Australian Public Assessment Report
Device/Product Name
Vitrakvi
Active ingredients
Larotrectinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-02585-1-5
Submission Type
New chemical entity
Decision
Approved for provisional registration